In type 1 diabetes, the body’s own immune system turns against the pancreas. Cells meant to protect you start destroying ...

Autoantibodies against GFAP may represent a new and early serum marker of high diabetes ... (1:150), 3.5, 5, 6, 8, 10 and 20 weeks old, respectively; lane 8, 1:1,000 IgG GFAP antibody. B-and T ...

The symptomatic onset of type 1 diabetes results from a T-cell mediated destruction of insulin-producing beta cells in the pancreas. CD4 + helper T cells orchestrate the autoimmune response ...

Researchers led by Maike Sander, Scientific Director of the Max Delbrück Center, have developed a vascularized organoid model of hormone secreting cells in the pancreas.

Researchers have found that Sotyktu, which inhibits the protein TYK2, protects insulin-producing beta cells and, at the same time, is able to reduce inflammation.

I'm talking about the advancement of islet pancreatic cells being ... patients with Type 1 Diabetes. It has not only shown to achieve continual survival of implanted pancreatic beta cells [through ...

"Type 1 diabetes is a T cell-mediated autoimmune disease arising from the destruction of pancreatic ... interleukin-2 functions as a proxy for anti-beta cell autoimmunity. The researchers ...

In Type 1 diabetes, the immune system mistakes the body’s healthy cells for foreign ones and tries to fight them. In this case, the immune system attacks and destroys the insulin-producing beta ...

Type 1 diabetes occurs when the immune system attacks pancreatic beta cells. Type 2 diabetes happens when the body cannot use insulin effectively. The two types differ in symptoms, causes ...

Researchers have uncovered a new way to slow or even prevent the destruction of these ... same mechanism could help protect beta cells in people with type 1 diabetes. Early lab tests using human ...